#Sweden #Brand Identity #Lund #Clinical Research #TFS HealthScience

TFS HealthScience Unveils New Global Brand Identity

In a significant development for the clinical research sector, TFS HealthScience has officially revealed its new global brand identity. This announcement, made on October 5, 2026, highlights the organization's commitment to delivering excellence in clinical research through collaboration with partners in biotechnology, pharmaceuticals, and medical technology.

Understanding the New Identity

Located in Lund, Sweden, TFS HealthScience has long been at the forefront of clinical research innovation. The new identity, which includes the slogan ‘Securing the path from science to life’, aims to enhance how the organization communicates its core values. TFS’s dedication to radical honesty, scientific urgency, and a therapeutic depth is underscored in this rebranding effort.

Markus Granlund, the CEO of TFS, stated, “Our new brand image perfectly embodies who we are and where we are headed. We are dedicated to securing the transition between science and life through our exceptional team.” This statement emphasizes the human-centric approach that TFS strives to maintain throughout the research process.

Commitment to Transparency and Excellence

The new branding encapsulates TFS's commitment to transparency. The organization aims to be clear and direct in its communication with sponsors, ensuring that the data reveal important insights quickly. Furthermore, the emphasis on scientific urgency means that therapeutic leads have the decision-making power necessary to expedite progress without excessive bureaucratic delays.

The focus areas for TFS remain in five therapeutic areas: dermatology, internal medicine, neuroscience, oncology, and ophthalmology. The expertise within these areas ensures that clinical leaders are well-versed in their respective indications prior to study initiation. This depth of knowledge supports the organization in communicating effectively with stakeholders and streamlining the clinical trial bridge from concept to realization.

A Unique Approach to Team Stability

One of the remarkable aspects of TFS’s operational strategy is its emphasis on team stability. With 88% of study teams remaining consistent throughout a trial's lifecycle, TFS stands 8 percentage points higher than the industry average. This continuity ensures that the same professionals who initiate studies are involved right up to the database lock, providing invaluable context and insight throughout the research process.

Excellent partnerships are crucial in clinical research. TFS allows clients to collaborate in various ways—through comprehensive service provisions, integrated resources, or tailored combinations that best meet their needs. This flexibility helps TFS maintain strong ties with sponsors while ensuring the smooth progression of their projects.

About TFS HealthScience

Founded in 1996, TFS HealthScience has grown its footprint across over 40 countries. Through its unwavering mission to expedite the journey from scientific inquiry to patient care, TFS remains committed to supporting significant therapeutic advancements. For more information about TFS and its newly launched brand identity, interested parties can visit tfscro.com.

The unveiling of this new identity marks a pivotal moment for TFS HealthScience as it continues to evolve within the clinical research landscape, staying firmly focused on the overarching goal of bringing essential medical innovations to those who need them most. With its renewed branding, TFS is prepared to navigate future challenges and maintain its role as a leader in the clinical research community.